文献速递新发突发、热带与寄生虫病

脑型疟疾中的氧化与亚硝化应激:能否作为改善不良预后的靶点?

Oxidative and nitrosative stresses in cerebral malaria: can we target them to avoid a bad prognosis?
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

本文讨论活性氧与活性氮中间体在脑型疟疾宿主-寄生虫相互作用中的作用,并综述基于氧化与亚硝化应激的抗疟药物对疾病治疗和控制的潜在贡献。现有抗疟药被认为有效,但部分国家已出现寄生虫耐药;治疗时机对降低脑型疟疾死亡与后遗症至关重要。

要点

  • 脑型疟疾治疗时机决定死亡与后遗症风险
  • 部分国家已观察到寄生虫对抗疟药耐药
  • 氧化与亚硝化应激通路可能是治疗靶点

核心结论

  • 活性氧与活性氮中间体在脑型疟疾的宿主-寄生虫相互作用中发挥作用,基于氧化与亚硝化应激的抗疟药物可能对疾病治疗和控制有潜在贡献。

研究设计与样本

  • 综述,讨论活性氧与活性氮中间体在脑型疟疾中的作用及氧化与亚硝化应激为基础的抗疟药物的潜在贡献。

主要发现

  • 现有抗疟治疗被认为有效,但在一些国家已观察到寄生虫对这些药物的耐药。
  • 抗疟药物通过增加寄生虫裂解发挥作用,尤其通过靶向氧化应激通路。
  • 治疗时机对降低脑型疟疾等重症疟疾相关死亡与后遗症起决定性作用。

临床怎么用

  • 关注脑型疟疾治疗时机以降低死亡与后遗症风险。
  • 在已报告耐药的国家需考虑寄生虫耐药对治疗的影响。
  • 氧化与亚硝化应激通路可作为潜在治疗靶点进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is currently a global effort to reduce malaria morbidity and mortality. However, malaria still results in the deaths of thousands of people every year. Malaria is caused by Plasmodium spp., parasites transmitted through the bite of an infected female Anopheles mosquito. Treatment timing plays a decisive role in reducing mortality and sequelae associated with the severe forms of the disease such as cerebral malaria (CM). The available antimalarial therapy is considered effective but parasite resistance to these drugs has been observed in some countries. Antimalarial drugs act by increasing parasite lysis, especially through targeting oxidative stress pathways. Here we discuss the roles of reactive oxygen species and reactive nitrogen intermediates in CM as a result of host-parasite interactions. We also present evidence of the potential contribution of oxidative and nitrosative stress-based antimalarial drugs to disease treatment and control.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Pereira DMS, Carvalho Júnior AR, Lacerda EMDCB, et al. Oxidative and nitrosative stresses in cerebral malaria: can we target them to avoid a bad prognosis? J Antimicrob Chemother. 2020. PMID: 32105324. doi:10.1093/jac/dkaa032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。